Skip to content

Design Therapeutics, Inc. DSGN Operating Lease Liabilities

Operating Lease Liabilities at other companies

ALN
Alnylam PharmaceuticalsALNY
$218.03M-5.2%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$61.4M-23.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$183.56M-9.1%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$14.27M-21.7%
Vor Biopharma logo
Vor BiopharmaVOR
$2.63M-90.1%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$17.77M+3.9%

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$860.66M+305%
Enterprise value$850.62M+324%

Profitability

See full
Operating margin-3,685.8%
Net margin-3,663.7%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Design Therapeutics, Inc.'s operating lease liabilities?
Design Therapeutics, Inc. (DSGN) reported operating lease liabilities of $2.2M in Q1 2026.
How has Design Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
Design Therapeutics, Inc.'s operating lease liabilities increased by 66.5% year-over-year, from $1.32M to $2.2M.
What is the long-term trend for Design Therapeutics, Inc.'s operating lease liabilities?
Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s operating lease liabilities has grown at a -32.7% compound annual growth rate (CAGR), from $3.14M to $645K.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.